Navigation Links
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Date:3/23/2009

New Indication is One of Three FDA Approvals Spanning Lilly Neuroscience Brands

INDIANAPOLIS, March 23 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax(R) (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company (NYSE: LLY) announced today. Symbyax is now the first drug approved by the FDA for the acute treatment of treatment-resistant depression (TRD).

"Living with major depressive disorder is difficult and distressing for anyone, but even more so for patients whose symptoms continue despite treatment," said Lilly Medical Director Dr. Sara Corya. "Until today, there has been no approved medication for treatment-resistant depression. Now, after two failed attempts with other antidepressants, doctors and patients have a new treatment option."

In other actions, the FDA approved two new combination indications for Zyprexa(R) (olanzapine) and fluoxetine for the acute treatment of bipolar depression and TRD. Lilly originally developed Prozac(R) (fluoxetine HCl), the branded version of fluoxetine.

Additionally, the format of the product labels was updated according to the Physician's Labeling Rule (PLR), which many consider easier to understand. Additions were also made to the Medication Guides for Symbyax and Prozac, and a new Medication Guide was created for Zyprexa. Medication Guides include information for patients about potential risks associated with a particular product.

"Lilly maintains its commitment to patients by the continued research of Zyprexa, Symbyax, and Prozac," said Dr. Cherri Miner, Lilly neuroscience senior medical director. "Today's new indications confirm that these medications are valuable tools for patients in the fight against severe and disabling mental illness, and expan
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the only full-service ... national chief nursing officer recruitment for Capital Health in Pennington, ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... leadership solutions firm B. E. Smith, Tri-City Medical Center in Oceanside, ... with a proven record of leading organization-wide compliance adaptation efforts and growing a ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... Research ... Examination Kit (Peek) smartphone app to test eyesight was just as accurate as those ... School of Hygiene and Tropical Medicine is responsible for the development of the test, ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO ... With larger-than-average weighing pans, ML-T balances give operators the room they need to ... extra real estate makes ML-T balances a perfect choice for day-to-day weighing in ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... Northbound team as Director of Referral Relations. , Emily originally entered the ... where she designed and implemented unique academic curriculum for clients to engage in ...
Breaking Medicine News(10 mins):Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... more information, more, expertise and more options in their ... Oct. 23 As more than 7,000 leaders and,providers ... Meeting and Exposition,of the American Association of Homes and ... in Orlando, Florida, to explore the future of aging,services, ...
... WLAN provides Palmer with critical access control features and ... support for bandwidth-intensive applications, ... Conference -- Colubris Networks, the leading global provider of,intelligent ... that Palmer College of Chiropractic, the largest,chiropractic college in ...
... patients left hospital about 3 days sooner, study found , ... respiratory patients in the intensive care unit can shorten the ... , Respiratory failure patients in the ICU who received ... breathing tube stayed in the hospital an average of three ...
... shows that religion and spirituality are linked to positive ... on people with life threatening diseases. A new study ... many individuals with disabilities adjust to their impairments and ... the study, persons facing impending death may use religion ...
... WASHINGTON, DC October 22, 2007 Researchers ... the Cardiovascular Research Foundation (CRF), will present new ... cardiology: percutaneous procedures to repair and replace defective ... are currently approved only in Europe, are under ...
... scientific symposium of the Cardiovascular Research Foundation (CRF), show that ... 2 ) can reduce the amount of damaged heart muscle ... restoration of blood flow to the heart with angioplasty following ... infarction, or damaged heart muscle caused by the death of ...
Cached Medicine News:Health News:'Will You Still Love Me, Will You Still Need Me, When I'm 84?' 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 2Health News:Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses 3Health News:Physical Therapy Shortens ICU Stay 2Health News:Religion and healthcare should mix, MU study says 2Health News:Percutaneous valve therapy: is it safe and effective? 2
(Date:7/1/2015)... June 24, 2015 ... addition of the "Future Horizons and Growth ... Supplier Shares and Country Forecasts" report to ... Strategies in the European Blood Banking Market 2015 ... to help current suppliers and potential market entrants ...
(Date:7/1/2015)... Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... disease and neurologic disorders, announced today the results of ... the Company,s lead compound. Results from the study show ... significantly inhibit the activation of inflammatory proteins in the ... compound in a Phase 1 clinical trial under a ...
(Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
... March 22 Royal Philips Electronics ( PHG, ... medical alert service.  This integrated solution offers an added ... medical alert service with automatic fall detection capabilities. Lifeline ... can automatically call for help if a fall is ...
... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. ... of the NYSE Amex LLC (the "Exchange") has granted the Company an ... Company will remain listed up to June 23, 2010 , subject ... progress towards the Company,s plan to regain compliance. , ...
Cached Medicine Technology:Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 2Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 3Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 4Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 5Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 6NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
3.5 mm blade. Round handle. Designated most popular model or size....
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
Medicine Products: